Monoamine neurons in the human brain stem: Anatomy, magnetic resonance imaging findings, and clinical implications

NeuroReport

Volumn 19, Issue 17, 2008, Pages 1649-1654

  Sasaki, Makoto ^a   Shibata, Eri ^a   Tohyama, Koujiro ^a   Kudo, Kohsuke ^a   Endoh, Jin ^a   Otsuka, Kotaro ^a   Sakai, Akio ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Locus ceruleus; Magnetic resonance imaging; Monoamine nuclei; Neuromelanin; Raphe nuclei; Substantia nigra

Indexed keywords

NEUROMELANIN;

BRAIN STEM; CELL NUCLEUS; DEGENERATIVE DISEASE; DEPRESSION; DOPAMINERGIC NERVE CELL; HUMAN; LOCUS CERULEUS; MENTAL DISEASE; MONOAMINERGIC SYSTEM; NORADRENERGIC NERVE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAPHE NUCLEUS; REVIEW; SCHIZOPHRENIA; SEROTONINERGIC NERVE CELL; SIGNAL DETECTION; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

BIOGENIC MONOAMINES; BRAIN STEM; HUMANS; LOCUS COERULEUS; MAGNETIC RESONANCE IMAGING; MODELS, ANATOMIC; NEURODEGENERATIVE DISEASES; NEURONS; SUBSTANTIA NIGRA;

EID: 56749085840     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e328315a637     Document Type: Review

References (25)

1. Crossman AK. Brain stem. In: Standring S, editor. Gray's anatomy; the anatomical basis of clinical practice. Edinburgh: Churchill Livingston; 2005. pp. 327-351.
2. Haines DE. Fundamental neuroscience for basic and clinical applications. Philadelphia: Elsevier; 2006.
3. Martin AR, Wallace BG, Fuchs PA, Nicholls JG, editors. From neuron to brain. Sunderland: Sinauer Associates; 2001.
4. Nieuwenhuys R, Voogd J, Van Huijzen C. The human central nervous system. Berlin: Springer; 2008. pp. 889-916.
5. DeArmond SJ, Fusco MM, Dewey MM. Structure of the human brain. New York: Oxford University Press; 1989. pp. 78-113.
6. German DC, Walker BS, Manaye K, Smith WK, Woodward DJ, North AJ. The human locus coeruleus: computer reconstruction of cellular distribution. J Neurosci 1988; 8:193-203.
7. Baker KG, Tork I, Hornung JP, Halasz P. The human locus coeruleus complex: an immunohistochemical and three dimensional reconstruction study. Exp Brain Res 1989; 77:257-270.
8. Dahlstrom A, Fuxe K. Evidence for the existence of monoamine-containmg neurons in the central nervous system. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand 1964; 62:1-55.
9. Mann DM, Yates PO. Possible role of neuromelanin in the pathogenesis of Parkinson's disease. Mech Ageing Dev 1983; 21:193-203.
10. Zarow C, Lyness SA, Mortimer JA, Chui HC. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 2003; 60:337-341.
11. Siever LJ, Davis KL. Overview: toward a dysregulation hypothesis of depression. Am J Psychiatry 1985; 142:1017-1031.
12. Mackay AV, Iversen LL, Rossor M, Spokes E, Bird E, Arrequi A, et al. Increased brain dopamine and dopamine receptors in schizophrenia. Arch Gen Psychiatry 1982; 39:991-997.
13. Drayer B, Burger P, Darwin R, Riederer S, Herfkens R, Johnson GA. MRI of brain iron. AJR Am J Roentgenol 1986; 147:103-110.
14. Rutledge JN, Hilal SK, Silver AJ, Defendini R, Fahn S. Study of movement disorders and brain iron by MR. AJR Am J Roentgenol 1987; 149:365-379.
15. Oikawa H, Sasaki M, Tamakawa Y, Ehara S, Tohyama K. The substantia nigra in Parkinson disease: proton density-weigh ted spin-echo and fast short inversion time inversion-recovery MR findings. AJNR Am J Neuroradiol 2002; 23:1747-1756.
16. Sasaki M, Inoue T, Tohyama K, Oikawa H, Ehara S, Ogawa A. High-field MRI of the central nervous system: current approaches to clinical and microscopic imaging. Magn Reson Med Sci 2003; 2:133-139.
17. Sasaki M, Shibata E, Tohyama K, Thakahashi J, Otsuka K, Tsuchiya K, et al. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Neuroreport 2006; 31:1215-1218.
18. Enochs WS, Petherick P, Bogdanova A, Mohr U, Weissleder R. Paramagnetic metal scavenging by melanin. MR imaging. Radiology 1997; 204:417-423.
19. Tosk JM, Holshouser BA, Aloia RC, Hinshaw DB Jr, Hasso AN, MacMurray JP, et al. Effects of the interaction between ferric iron and L-dopa melanin on T1 and T2 relaxation times determined by magnetic resonance imaging. Magn Reson Med 1992; 26:40-45.
20. Shibata E, Sasaki M, Tohyama K, Kanbara Y, Otsuka K, Ehara S, et al. Age-related changes in the locus ceruleus on neuromelanin magnetic resonance imaging at 3 Tesla. Magn Reson Med Sci 2006; 5:197-200.
21. Duguid JR, De La Paz R, DeGroot J. Magnetic resonance imaging of the midbrain in Parkinson's disease. Ann Neurol 1986; 20:744-747.
22. Huber SJ, Chakeres DW, Paulson GW, Khanna R. Magnetic resonance imaging in Parkinson's disease. Arch Neurol 1990; 47:735-737.
23. Stern MB, Braffman BH, Skolnick BE, Hurtig HI, Grossman RI. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes. Neurology 1989; 39:1524-1526.
24. Shibata E, Sasaki M, Tohyama K, Otsuka K, Sakai A. Reduced signal of locus ceruleus in depression in quantitative neuromelanin magnetic resonance imaging. Neuroreport 2007; 18:415-418.
25. Shibata E, Sasaki M, Tohyama K, Otsuka K, Endoh J, Terayama Y, et al. Use of neuromelanin-sensitive MRI to distinguish schizophrenic and depressive patients and healthy individuals based on signal alteration in the substantia nigra and locus ceruleus. Biol Psychiatry 2008; 64:401-406.